PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.64
Bid: 15.52
Ask: 15.64
Change: 0.26 (1.69%)
Spread: 0.12 (0.773%)
Open: 15.28
High: 15.64
Low: 15.14
Prev. Close: 15.38
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of New Ordinary Shares

21 Nov 2016 08:00

RNS Number : 6616P
EnQuest PLC
21 November 2016
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN AND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

EnQuest PLC, 21 November 2016

Placing and Open Offer

Admission of New Ordinary Shares

Further to the announcement made by EnQuest PLC ("EnQuest" or the "Company") on 17 November 2016, the Company announces that 356,738,114 New Ordinary Shares being issued pursuant to the Placing and Open Offer were admitted to listing on the premium listing segment of the Official List and were admitted to trading on the London Stock Exchange's main market for listed securities, in each case with effect from 8.00 a.m. today, 21 November 2016.

It is expected that admission of the New Ordinary Shares to trading on NASDAQ Stockholm will become effective later today.

The enlarged share capital of the Company following Admission will be 1,159,398,871 Ordinary Shares in aggregate. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.

This announcement should be read in conjunction with the full text of the combined circular and prospectus (the "Prospectus") published by the Company on 14 October 2016 in connection with the Placing and Open Offer. Unless defined herein, capitalised terms used in this announcement shall have the meaning attributed to them in the Prospectus.

ENQUIRIES

EnQuest PLC

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Michael Waring (Head of Communications & Investor Relations)

Tel: +44 (0)20 7925 4900

 

Sponsor and Joint Bookrunner

J.P. Morgan Cazenove

Barry Weir

Jamie Riddell

Charles Pretzlik

 

Tel: +44 (0)20 7742 4000

 

Joint Bookrunner

Bank of America Merrill Lynch

Julian Mylchreest

Richard Abel

Daniel Norman

 

Tel: +44 (0)20 7628 1000

IMPORTANT NOTICE

This announcement has been issued by and is the sole responsibility of EnQuest. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the information contained in this announcement or on its accuracy or completeness. The information in this announcement is subject to change.

This announcement does not contain or constitute an offer to sell or the solicitation of an offer to purchase securities to any person with a registered address in, or who is resident in, any Excluded Territory or in any jurisdiction in which such an offer or solicitation is unlawful. None of the securities referred to herein have been or will be registered under the relevant laws of any state, province or territory in any Excluded Territory. Subject to certain limited exceptions, none of these materials will be released, published, distributed or forwarded in or into any Excluded Territory.

 

This announcement is for information purposes only and is not intended to and does not constitute or form part of any offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities in any jurisdiction. No offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for, any securities will be made in any jurisdiction in which such an offer or solicitation is unlawful. The information contained in this announcement is not for release, publication or distribution to persons in the United States or any other Excluded Territory, and should not be distributed, forwarded to or transmitted in or into any jurisdiction, where to do so might constitute a violation of local securities laws or regulations.

 

This announcement has been prepared in accordance with English law, the EU Market Abuse Regulation and the Disclosure Guidance Rules and Transparency Rules of the Financial Conduct Authority and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

 

The distribution of this announcement into jurisdictions other than the United Kingdom and Sweden may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction. In particular, subject to certain exceptions, this announcement should not be distributed, forwarded to or transmitted in or into the United States or any other Excluded Territory.

 

 

NOTICE TO ALL INVESTORS

 

J.P. Morgan Securities plc (which conducts its UK investment banking services as "J.P. Morgan Cazenove") and Merrill Lynch International ("BofA Merrill Lynch") are each authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority. J.P. Morgan Cazenove and BofA Merrill Lynch are acting for EnQuest and are acting for no one else in connection with the Placing and Open Offer and will not regard any other person as a client in relation to the Placing and Open Offer and will not be responsible to anyone other than EnQuest for providing the protections afforded to their respective clients, nor for providing advice in connection with the Placing and Open Offer or any other matter, transaction or arrangement referred to herein.

 

 

No person has been authorised to give any information or to make any representations other than those contained in this announcement and the Prospectus and, if given or made, such information or representations must not be relied on as having been authorised by EnQuest or J.P. Morgan Cazenove or BofA Merrill Lynch. Subject to the Listing Rules, the Prospectus Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the issue of this announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of EnQuest since the date of this announcement or that the information in it is correct as at any subsequent date.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISFEASWFFMSESF
Date   Source Headline
2nd Feb 20157:00 amRNSEnQuest exits Tunisia
23rd Jan 20157:00 amRNSEnquest PLC, Trading and Operations Update
24th Dec 201412:10 pmRNSDirector/PDMR Shareholding
16th Dec 201411:00 amRNSDirector/PDMR Shareholding
2nd Dec 20144:29 pmRNSDirector/PDMR Shareholding
28th Nov 20144:20 pmRNSDirector/PDMR Shareholding
25th Nov 20145:10 pmRNSDirector/PDMR Shareholding
21st Nov 201411:56 amRNSDirector/PDMR Shareholding
12th Nov 20147:00 amRNSInterim Management Statement
7th Nov 20145:07 pmRNSDirector/PDMR Shareholding
7th Nov 201410:28 amRNSHolding(s) in Company
6th Nov 20149:00 amRNSResult of Meeting
31st Oct 201410:50 amRNSDirector/PDMR Shareholding
21st Oct 20144:00 pmRNSDirector/PDMR Shareholding
17th Oct 20143:45 pmRNSDirector/PDMR Shareholding
17th Oct 20141:30 pmRNSNotice of Adjourned Meeting - Retail Note Holders
10th Oct 20141:45 pmRNSDirector/PDMR Shareholding
8th Oct 20144:31 pmRNSDirector/PDMR Shareholding
2nd Oct 20149:55 amRNSDirector/PDMR Shareholding
22nd Sep 20147:00 amRNSNotice for Retail Note Holders
19th Aug 201411:45 amRNSDirector/PDMR Shareholding
18th Aug 20141:30 pmRNSHolding(s) in Company
13th Aug 20147:00 amRNSHalf Yearly Report
11th Aug 20141:00 pmRNSHolding(s) in Company
13th Jun 20147:04 amRNSAcquisition
28th May 20144:30 pmRNSResult of AGM
16th May 20147:00 amRNSInterim Management Statement
9th May 20144:23 pmRNSHolding(s) in Company
8th May 20149:58 amRNSDirector/PDMR Shareholding
1st May 20144:05 pmRNSDirector/PDMR Shareholding
24th Apr 20145:06 pmRNSAnnual Report and Accounts Disclosure
24th Apr 201410:15 amRNSDirector/PDMR Shareholding
23rd Apr 20143:23 pmRNSDirector/PDMR Shareholding
10th Apr 20147:00 amRNSClose announcement of $650 million senior notes
8th Apr 20149:57 amRNSDirector/PDMR Shareholding
7th Apr 20147:00 amRNSPricing announcement of $650 million senior notes
3rd Apr 201412:12 pmRNSDirector/PDMR Shareholding
26th Mar 20147:02 amRNSEnQuest PLC proposes to offer senior notes
26th Mar 20147:00 amRNSFinal Results
3rd Mar 20147:00 amRNSAcquisition
14th Jan 201412:05 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
26th Nov 20131:42 pmRNSDirector/PDMR Shareholding
25th Nov 20136:16 pmRNSFinal Terms Confirmation Announcement
20th Nov 201311:44 amRNSPublication of Final Terms
18th Nov 20131:12 pmRNSUpdate
18th Nov 20131:11 pmRNSPublication of Supplementary Prospectus
15th Nov 20137:00 amRNSInterim Management Statement
22nd Oct 20137:00 amRNSAcquisition
17th Oct 201311:43 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
17th Oct 201311:30 amRNSChange of Company Secretary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.